Apolipoprotein H (Beta-2-Glycoprotein I) (APOH) (Middle Region) Peptide
APOH
Reactivity: Human
Host: Synthetic
BP, WB, IHC
-
- Target See all APOH products
- APOH (Apolipoprotein H (Beta-2-Glycoprotein I) (APOH))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-APOH antibody (Catalog #: ARP51159_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- APOH (Apolipoprotein H (Beta-2-Glycoprotein I) (APOH))
- Background
-
Apolipoprotein H has been implicated in a variety of physiologic pathways including lipoprotein metabolism, coagulation, and the production of antiphospholipid autoantibodies. APOH may be a required cofactor for anionic phospholipid binding by the antipho
Alias Symbols: B2G1, BG, B2GP1
Protein Interaction Partner: ANXA2,F10,F12,LPA,LRP2,LRP8,PLG,ANXA2,LRP2,LRP8
Protein Size: 345 - Molecular Weight
- 36 kDa
- Gene ID
- 350
- NCBI Accession
- NM_000042, NP_000033
- UniProt
- P02749
-
You are here:
